Show simple item record

dc.contributor.authorBurt, Deborah J
dc.contributor.authorJohnston, Diane
dc.contributor.authorRinke de Wit, T
dc.contributor.authorVan den Elsen, P
dc.contributor.authorStern, Peter L
dc.date.accessioned2010-06-11T11:36:47Z
dc.date.available2010-06-11T11:36:47Z
dc.date.issued1991
dc.identifier.citationCellular immune recognition of HLA-G-expressing choriocarcinoma cell line Jeg-3. 1991, 6:117-22 Int. J. Cancer Suppl.en
dc.identifier.issn0898-6924
dc.identifier.pmid2066177
dc.identifier.urihttp://hdl.handle.net/10541/104714
dc.description.abstractJeg-3 choriocarcinoma cells express class-I MHC HLA-G and low levels of a novel HLA-C product. The functional significance of such novel MHC class-I expression in regard of the cellular immune response has been investigated. Jeg-3 cells are NK-insensitive, but susceptible to LAK cytotoxicity, some of which is mediated by T cells. No Jeg-3-specific CTL or proliferative responses could be generated in allogeneic responder PBMC from several different donors. There was no detectable xenogeneic recognition of Jeg-3 cells even when preceded by in vivo priming. Jeg-3 cells are able to suppress proliferative responses in humans and others species. This is not reproduced by conditioned medium from the Jeg-3 cells, but can be overridden by IL-2. The ability of the Jeg-3 choriocarcinoma (trophoblast) cells to suppress in the MLR may reflect the processes which are shared to enable the survival of the foetus in a semi-allogeneic mother or a tumour in its host. It is not clear whether there is any relationship between the unusual class-I-MHC expression by trophoblast and the putative regulatory properties of the latter.
dc.language.isoenen
dc.subjectCancer Transplantationen
dc.subject.meshAnimals
dc.subject.meshCell Line
dc.subject.meshChoriocarcinoma
dc.subject.meshCytotoxicity, Immunologic
dc.subject.meshDNA Replication
dc.subject.meshHLA Antigens
dc.subject.meshHistocompatibility Antigens Class I
dc.subject.meshHumans
dc.subject.meshKiller Cells, Lymphokine-Activated
dc.subject.meshKiller Cells, Natural
dc.subject.meshLymphocyte Activation
dc.subject.meshMice
dc.subject.meshNeoplasm Transplantation
dc.subject.meshT-Lymphocytes
dc.subject.meshT-Lymphocytes, Cytotoxic
dc.subject.meshTeratoma
dc.subject.meshTransplantation, Heterologous
dc.titleCellular immune recognition of HLA-G-expressing choriocarcinoma cell line Jeg-3.en
dc.typeArticleen
dc.contributor.departmentCancer Research Campaign Department of Immunology, Paterson Institute for Cancer Research, Christie Hospital and Holt Radium Institute, Manchester, UK.en
dc.identifier.journalInternational Journal of Cancer. Supplementen
html.description.abstractJeg-3 choriocarcinoma cells express class-I MHC HLA-G and low levels of a novel HLA-C product. The functional significance of such novel MHC class-I expression in regard of the cellular immune response has been investigated. Jeg-3 cells are NK-insensitive, but susceptible to LAK cytotoxicity, some of which is mediated by T cells. No Jeg-3-specific CTL or proliferative responses could be generated in allogeneic responder PBMC from several different donors. There was no detectable xenogeneic recognition of Jeg-3 cells even when preceded by in vivo priming. Jeg-3 cells are able to suppress proliferative responses in humans and others species. This is not reproduced by conditioned medium from the Jeg-3 cells, but can be overridden by IL-2. The ability of the Jeg-3 choriocarcinoma (trophoblast) cells to suppress in the MLR may reflect the processes which are shared to enable the survival of the foetus in a semi-allogeneic mother or a tumour in its host. It is not clear whether there is any relationship between the unusual class-I-MHC expression by trophoblast and the putative regulatory properties of the latter.


This item appears in the following Collection(s)

Show simple item record